<DOC>
	<DOCNO>NCT00131443</DOCNO>
	<brief_summary>The objective study ass effectiveness safety topiramate prevention basilar hemiplegic migraine child adolescent .</brief_summary>
	<brief_title>Dose Comparison Study Topiramate Pediatric Subjects With Basilar/Hemiplegic Migraine</brief_title>
	<detailed_description>The objective study assess efficacy safety topiramate prophylaxis basilar migraine hemiplegic migraine child adolescent , compare two dos , 25 100 mg/day .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Migraine Aura</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Must meet International Headache Society ( IHS ) classification pediatric migraine aura : familial hemiplegic migraine ( International Classification Headache Disorders [ ICHD ] 1.2.4 ) , sporadic hemiplegic migraine ( ICHD 1.2.5 ) basilartype migraine ( ICHD 1.2.6 ) . Average 4 migrainedays/month 3 month prior screen . 4 migrainedays prospective baseline period . At least one subject 's migraine previous 3 month must accompany characteristic basilartype hemiplegic neurologic symptom moderate severe degree . 618 year age . Weigh 25 kg . If female , subject must : 1. premenarchal otherwise incapable pregnancy , 2. practice one follow method contraception least one month prior study entry : hormonal contraceptive , spermicide barrier , intrauterine device , spousal/partner sterility , 3. practicing abstinence agree continue abstinence use acceptable method contraception ( list ) sexual activity commence . If ( b ) ( c ) , subject must negative urine pregnancy test within one week study entry . Able take oral medication tablet form Willing able : 1. read comprehend write instruction , 2. complete assessment form , 3. return regular visit , ) adhere medication regimen . Previously fail topiramate therapy migraine prophylaxis discontinue topiramate due adverse event . Have take topiramate within 14 day prior start prospective baseline period . Have 15 headachedays prospective baseline period . Have cluster headache chronic migraine . Have migraine aura without headache exclusively . Currently painful condition migraine pain . Have take medication migraine prophylaxis , within 2 week start prospective baseline period . Progressive neurological disorder structural disorder brain Overuse analgesic migrainespecific agent abortive treatment migraine : &gt; 10 treatment days/month ergotcontaining medication , triptans , opioids ; &gt; 15 treatment days/month simple analgesic ( include NSAIDs ) Require injection corticosteroid local anesthetic within 60 day visit 1 botulinum toxin within 120 day prior Visit 1 . Have previously fail 2 adequate trial establish prophylactic antimigraine regimen . Subjects start nonpharmacologic prophylactic approach within 1 month prior Visit 1 . Nonpharmacologic prophylactic approach start least 1 month prior Visit 1 continue throughout study . Have take carbonic anhydrase inhibitor triamterene within 1 month prior Visit 1 . History nephrolithiasis . Require continue treatment anticonvulsant therapy nonmigraine condition . Significant major psychiatric disorder ( e.g. , major depression ) subject receive antipsychotic medication . History attempt suicide suicidal tendency . History substance abuse . Pregnant lactating female . Clinically unstable neurological , cardiovascular , gastrointestinal , musculoskeletal , pulmonary disease . Active liver disease . AST and/or ALT level great 2 time upper limit normal range . Received investigational drug use investigational device within 30 day study entry .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Basilar/Hemiplegic Migraine</keyword>
	<keyword>Prophylaxis</keyword>
</DOC>